Research
Pharma analytical teardowns, segment comparisons, comparative analysis, financial valuations and much more.
Analytical Teardowns
Most recent institutional grade analysis of open innovation, M&A, and external capital deployment at the world's top Pharma companies.
Coming Soon!
Comparative Analysis
Cross company comparisons, segment analysis, therapeutic area strategies and portfolio risk assessments.
Financial Analysis
Ex-ante vs. actual deal outcomes, NPV-adjusted deal portfolios, and rNPV/DCF-based assessment of whether capital deployment is paying off.